Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
19 Septiembre 2023 - 9:48AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant To Section 14(a) of the Securities Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commissions Only (as permitted
by Rule 14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material Pursuant to Section 240.14a-12 |
MICROBOT
MEDICAL INC. |
(Name of Registrant as Specified
in its Charter) |
N/A |
(Name of Person(s) Filing
Proxy Statement, if other than the Registrant) |
Payment
of Filing Fee (Check all boxes that apply):
☒ |
No fee required. |
|
|
☐ |
Fee paid previously with preliminary materials |
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b)
per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Microbot Medical (NASDAQ:MBOT)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Microbot Medical (NASDAQ:MBOT)
Gráfica de Acción Histórica
De May 2023 a May 2024